International Stem Cell (OTCMKTS:ISCO) Stock Price Passes Above 200-Day Moving Average – Here’s What Happened

Shares of International Stem Cell Corp. (OTCMKTS:ISCO) crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.17 and traded as high as $0.26. International Stem Cell shares last traded at $0.26, with a volume of 800 shares trading hands.

International Stem Cell Price Performance

The stock has a 50 day simple moving average of $0.19 and a 200-day simple moving average of $0.17. The firm has a market cap of $2.13 million, a PE ratio of -4.43 and a beta of -0.01.

International Stem Cell (OTCMKTS:ISCO) last released its earnings results on Thursday, May 14th. The biotechnology company reported ($0.03) EPS for the quarter. The firm had revenue of $2.32 million during the quarter.

About International Stem Cell

International Stem Cell Corporation (OTCMKTS:ISCO) is a biotechnology company focused on the development and commercialization of human parthenogenetic stem cells (hpSC) for therapeutic and research applications. Parthenogenetic stem cells are derived from unfertilized human eggs and offer a scalable, ethically noncontroversial source of pluripotent cells. ISCO’s proprietary hpSC lines can be directed to differentiate into a wide variety of cell types, enabling preclinical programs in areas such as neurodegenerative disease, liver disease, diabetes and corneal regeneration.

In addition to its therapeutic pipeline, International Stem Cell maintains a research products division that supplies hpSC lines, differentiated cell populations and media formulations to academic institutions, biotechnology companies and contract research organizations.